The report offers detailed coverage of Octreotide industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Octreotide by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically,it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
The production of Octreotide mainly focuses on Europe, China and India. The Europe occupies the largest share and it about reach 66.36% in 2015. Novartis exports to other countries mainly in the form of finished drug.
The Octreotide product increased fast in the past five years, the production growth in the past two years. There have been new manufacturers to enter the field year by year. But for now , it is difficult to obtain certification.
It will expect that the production and the capacity will increase fast in the future, But with octreotide acetate in China continues to mature in manufacturing technology, in the future, trade of octreotide API will gradually decrease, more and more Octreotide will sold as finished medicine.
The report forecast global Octreotide market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Octreotide market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
At the same time, we classify Octreotide according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Market by Application
Treating Severe Diarrhea
Treating Acromegaly
Others
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Octreotide market for the forecast period 2021 - 2025?
• What are the driving forces in the Octreotide market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Octreotide industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?